Urinary tract infections: diagnosis, antibiotic choice and recurrent UTI management
UTIs are a bread-and-butter topic for the AKT, but the guidelines (NICE/PHE) are quite specific about when to test and what to prescribe. Let's break this down into the three areas you mentioned.
The most important thing to remember for the exam is that diagnosis is primarily clinical for most women.
For an uncomplicated lower UTI, the first-line options are usually a 3-day course for women and a 7-day course for men/pregnant women.
| Scenario | First-line Antibiotic | Duration |
|---|---|---|
| Uncomplicated UTI (Women) | Nitrofurantoin (if eGFR >45) OR Trimethoprim | 3 Days |
| UTI in Pregnancy | Nitrofurantoin (avoid at term) | 7 Days |
| UTI in Men | Nitrofurantoin or Trimethoprim | 7 Days |
| Acute Pyelonephritis | Cefalexin or Co-amoxiclav | 7-10 Days |
Note: Avoid Nitrofurantoin if the eGFR is <45 as it won't reach effective concentrations in the bladder.
Recurrent UTI is defined as ≥2 episodes in 6 months or ≥3 episodes in 12 months.
I'll pull up some high-yield lessons and a flowchart to help you visualize the management pathway for recurrent cases.
📚 UTI Lessons
Those lessons cover the core theory, but let's look at a clinical algorithm for managing recurrent UTIs in women, as this is a common AKT scenario.
That flowchart should help you keep the management steps clear. One final high-yield tip for the AKT: always check the eGFR before prescribing Nitrofurantoin. If it's below 45, it's generally avoided (though some guidelines say 30-44 is okay for short courses if there's no other option).
Would you like to try a few practice questions on this topic to see how it's tested, or should we look at UTIs in specific groups like pregnancy or children?
Setting up chat...